{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-002702","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2025-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.908957+00:00","generated_at":"2026-05-23T22:08:52.545311+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AIM ImmunoTech enters ATM offering agreement for up to $3M common stock","bullets":["Entered Equity Distribution Agreement with Maxim Group LLC for at-the-market offering of up to $3M common stock.","Currently limited to selling $663,329 due to Form S-3 General Instruction I.B.6; registration statement not yet effective.","Maxim receives 3.0% commission on gross proceeds; expense reimbursement up to $50,000 initial, $5,000 quarterly.","Net proceeds to be used for working capital and general corporate purposes.","Agreement may be terminated by either party on 15 days' notice or after 24 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-002702","json":"https://secwatch.observer/filing/0001641172-25-002702.json","markdown":"https://secwatch.observer/filing/0001641172-25-002702.md","text":"https://secwatch.observer/filing/0001641172-25-002702.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000164117225002702/0001641172-25-002702-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000164117225002702/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T22:08:52.545311+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}